This podcast, which took place prior to the approval of pegcetacoplan, features Drs. Sadda, Modi, and Baumal discussing the newly approved and potential therapies as well as risk factors that drive the disease, imaging modalities that are best suited for GA evaluation, and the type of lesion patterns that place patients at high risk for progression.

This activity is supported by an unrestricted medical educational grant from Apellis Pharmaceuticals.

Click here to view this webinar event, which includes images from the talk.

Want to register with Evolve Medical Education? Click here.